OIT Effect on FAQLQ

Shamir Medical Center (Assaf-Harofeh)

Status: Unknown

Conditions: Food Allergy

Treatments: Other: Oral immunotherapy

Study type: Observational

Funder types: Other

Identifiers

NCT02375360

52/14

Details and patient eligibility

About

Patients with food allergy and their parents will answer a food allergy quality of life questionnaire that will be translated to Hebrew and validated. Questionnaires will be filled also by patients undergoing oral immunotherapy (OIT).

Full description

The food allergy quality of life questionnaires (FAQLQ) for children 8-12 y/o, teenagers 13-17 y/o and adults > 18 y/o and parents to children 0-12 y/o and to teenagers will be translated to Hebrew. Questionnaires will be given to patients with food allergy followed at Asaf Harofeh Medical Center. Questionnaires will be examined for internal consistency. The Food Allergy Independent Measure (FAIM) questionnaire for the same age groups will also be translated to Hebrew. The FAQLQ will be validated by correlation with the FAIM.

The questionnaires will then be administered to patients and families undergoing food oral immunotherpy, before during and following treatment.

Enrollment: 500 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with suspected food allergy

Exclusion criteria

• none

Trial design

500 participants in 7 patient groups

Children 8-12- control

Description:

Children aged 8-12 years with food allergy who are not undergoing oral immunoterapy

Parents 0-12 - control

Description:

Parents to children aged 0-12 years with food allergy who are not undergoing oral immunoterapy

Children 8-12 - OIT

Description:

Children aged 8-12 years with food allergy who are undergoing oral immunoterapy

Treatment:

Other: Oral immunotherapy

Teenagers 13-17 - OIT

Description:

Teenagers aged 13-17 years with food allergy who are undergoing oral immunoterapy

Treatment:

Other: Oral immunotherapy

Adults >18 - OIT

Description:

Adults\> 18 years with food allergy who are undergoing oral immunoterapy

Treatment:

Other: Oral immunotherapy

Parents 0-12 - OIT

Description:

Parents to children aged 0-12 years with food allergy who are undergoing oral immunoterapy

Treatment:

Other: Oral immunotherapy

Parents 13-17 - OIT

Description:

Parents to teenagers aged 13-17 years with food allergy who are undergoing oral immunoterapy

Treatment:

Other: Oral immunotherapy